DRY POWDER INHALERS

Conference Date: 30 Jun 2010-16 Aug 2010
Conference Ref: N6-8010
Fee: £1295 + VAT
Venue: Le Meridien Piccadilly, London

INTRODUCTION

This meeting will clearly focus on current issues that will affect the Pharma business to deliver inhaled products as new markets develop and another generation of inhalers become available.  This event has real potential to affect how you develop your inhaled respiratory product pipeline and how you develop your business strategy for the future.

WHO SHOULD ATTEND

This major international conference is a key event in the DPI and Respiratory calendar and will be of importance to Directors, Senior Executives in Research and Technical Development, Heads of Medical Device Departments, Business Development Managers, Product Development Managers and Project Co-ordinators in Manufacturing , R&D and Marketing.

THREE REASONS TO ATTEND

1. Key annual gathering for pharmaceutical and medical device professionals in the DPI market
2. Spotlight on advancing technologies
3. Technology showcase highlighting new devices

Co-Chairmen:
Day One: Dr Steve Nichols, OINDP Specialist Consultant, UK
Day Two: Dr Ian J Smith, Director H12 Consulting, formerly Executive Director, Pfizer Ltd, UK

With a panel of expert speakers

Key topics to include:

• Keynote Address:
  
• The Future Therapies – Emerging Future DPI Technology Emerging Markets:
• Review of Emerging Markets
• Obstructive Airway Diseases in India
• The Dry Powder Inhaler Market in China New Devices, Inhalers and Technologies:
• User Centred Design in DPI Development
• Connix Device
• SmartTrack on to DPI Devices
• Project DreamBoat: Application Optimization
• Modelling Performance of DPIs Advances in Therapies:
• How Does a DPI Aerolise a Powder Blend
• Why Advances in New Powder Science are Not Delivering
• Imaging the Geometry of the Respiratory Tract

Click here to book your place at this important event.